Redcare Pharmacy NV (HAM:RDC) ROCE %: -1.29% (As of Mar. 2026)


HAM:RDC Redcare Pharmacy NV HAM:RDC
14 GF Score
Price €64.85
GF Value €179.32
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Redcare Pharmacy NV ROCE %?

Redcare Pharmacy NV HAM:RDC -1.52% 14 ROCE % is -1.29% as of Mar. 2026. GuruFocus rates HAM:RDC with a GF Score™ of 14/100 and a GF Value™ of €179.32 (Significantly Undervalued). The stock has 2 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Redcare Pharmacy NV's annualized ROCE % for the quarter that ended in Mar. 2026 was -1.29%.

Redcare Pharmacy NV  (HAM:RDC) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Redcare Pharmacy NV ROCE % Related Terms

Redcare Pharmacy NV ROCE % Historical Data

* Premium members only.

The historical data trend for Redcare Pharmacy NV's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Redcare Pharmacy NV ROCE % Chart

Redcare Pharmacy NV Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -12.36 -11.92 -0.90 -5.17 -3.55

Redcare Pharmacy NV Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.08 7.48 -0.38 -16.55 -1.29
HAM:RDC
14GF Score
Redcare Pharmacy NV HAM:RDC
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Redcare Pharmacy NV ROCE % Calculation

Redcare Pharmacy NV's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=-27.8/( ( (1003.3 - 249.7) + (1214.3 - 400) )/ 2 )
=-27.8/( (753.6+814.3)/ 2 )
=-27.8/783.95
=-3.55 %

Redcare Pharmacy NV's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=-10.4/( ( (1214.3 - 400) + (1178.4 - 375.1) )/ 2 )
=-10.4/( ( 814.3 + 803.3 )/ 2 )
=-10.4/808.8
=-1.29 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -1.29% mean?
Redcare Pharmacy NV (HAM:RDC) has a ROCE % of -1.29% as of Mar. 2026.
Is Redcare Pharmacy NV's ROCE % too high?
Redcare Pharmacy NV's current ROCE % is -1.29%. Overall, Redcare Pharmacy NV has a GF Score™ of 14/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Redcare Pharmacy NV's ROCE % compare to competitors?
Redcare Pharmacy NV's ROCE % of -1.29% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.41. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Providers & Services company?
The median ROCE % among Healthcare Providers & Services companies is 6.41, based on 648 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Redcare Pharmacy NV's current ROCE % is -1.29%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Redcare Pharmacy NV stock overvalued right now?
Based on GuruFocus' analysis, Redcare Pharmacy NV (HAM:RDC) is currently considered Significantly Undervalued. The stock's GF Value™ is €179.32, compared to a current price of €64.85 — trading 63.8% below its estimated fair value. The current ROCE % is -1.29%. Redcare Pharmacy NV's overall GF Score™ is 14/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Redcare Pharmacy NV (HAM:RDC), the current ROCE % is -1.29% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Redcare Pharmacy NV (HAM:RDC) Overvalued in 2026?

Based on GuruFocus' analysis, Redcare Pharmacy NV stock appears to be undervalued. The current stock price of €64.85 is trading 63.8% below its estimated GF Value™ of €179.32. GuruFocus considers Redcare Pharmacy NV to be Significantly Undervalued.

Key valuation signals for HAM:RDC:

  • ROCE %: -1.29%
  • GF Value™: €179.32 vs. price of €64.85 (63.8% below fair value)
  • GF Score™: 14/100 with 2 warning signs

No single metric tells the full story. See the HAM:RDC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Redcare Pharmacy NV Business Description

Address Erik de Rodeweg 11/13, Sevenum, ZH, NLD, 5975 WD
Redcare Pharmacy NV is an online pharmacy business for prescription and nonprescription (over-the-counter) pharmaceuticals, beauty and personal care products (BPC) and food supplements. Besides OTC, nutritional supplements, beauty and personal care products as well as an extensive assortment of health-related products in all markets, the company also provides prescription drugs for customers in Germany, Switzerland and the Netherlands. It operates in two segments, namely DACH segment that includes sales in Germany, Austria and Switzerland; and the International segment that includes sales across Belgium, the Netherlands, France and Italy. The DACH segment accounts for the majority of the revenue.
14GF Score

Get the complete analysis for HAM:RDC

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€64.85
Price
€179.32
GF Value